Atossa Therapeutics Inc ATOS

$2.91 +0.26 (9.81%)

Valuation

Market cap
26,445,000
Revenue TTM
$0
Net income TTM
$-34,770,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
104,600
Avg volume
74,628
Day's range
$2.51 – $2.95
Shares out
9,979,000
Stochastic %K
79%
Beta
1.27
Analysts
Strong Sell
Price target
$17.00

Price

Company profile

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other thera...

Show more

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Industry
Biotechnology
Sector
Healthcare
Phone
206 588 0256
Website
https://www.atossatherapeutics.com
Address
448 NW Market Street, Suite 500, Seattle, United States

Latest news

Stocktwits

Bunster Oct 17, 3:29 PM
$ATOS IMO LOOKS LIKE 5 MONTHS CASH LEFT.Last raise was horrible. 1.36 mil shares for 4.5 mil dollars less expense plus same number of series A and B WARRANTS EXERCISESABLE I THINK AT 4.40 AFTER DEC 12. See my shadow CB, PRIME POSTS INFORMATIVE STUFF NOT BULLISH NONSENSE LIKE MOST HAVE POSTED OVER THE PAST3 PLUS YEARS.see prime has to keep up his mt rushmore of posters here image.
1 replies
Bunster Oct 17, 3:06 PM
$ATOS very few mgmt teams would let cash have this short of a runway like THE MD AND MD HAVE.
0 replies
TheChangedBear Oct 17, 2:04 AM
$ATOS Jesus Dumpster! Lets give that smooth brain a crease. https://www.statnews.com/2026/10/09/steven-quay-no-longer-in-consideration-for-top-infectious-disease-role/
1 replies
Bunster Oct 17, 12:55 AM
$ATOS week in review 3.00 i guess it be cause of cvr. my friend heisel got carried away with his bullish sentiment..still nothing on quay and possible job. weird so long like 8 weeks i think since politico..will offering come b4 data?prime is the only one here talking offering.its taboo among the bulls..Steven showed once again why he is one of our best contributors..
1 replies
RichardDangler Oct 16, 9:16 PM
$ATOS also, where’s fatass bunster?
1 replies
RichardDangler Oct 16, 9:16 PM
$ATOS held down for OpEx to let $3 calls expire worthless (thank you I’ll keep my $4K premium + shares) and it’s confirmed with large volume AH. All for shareholders to get in before Monday EOD to be considered for the CVR upon voucher sale. Great move by the company, big plus for long term holders who I would hope have been averaging down along the way. With data around the corner as well, things could shake up quite nicely here.
0 replies
DCalcote Oct 16, 8:56 PM
$ATOS Strong Steady Climb today! Let's have a beer and celebrate!
0 replies
ShowMeThaMonay Oct 16, 8:54 PM
$ATOS Nice AH but low volume spike
0 replies